Quốc gia: Úc
Ngôn ngữ: Tiếng Anh
Nguồn: Department of Health (Therapeutic Goods Administration)
gliclazide, Quantity: 60 mg
Sandoz Pty Ltd
Tablet, modified release
Excipient Ingredients: magnesium stearate; lactose monohydrate; hypromellose
Oral
60 tablets, 20 tablets
(S4) Prescription Only Medicine
Type II diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,During controlled clinical trials in patients with type II diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of HbA1c.
Visual Identification: White to off-white, biconvex oval shaped tablet with a deep break line on both sides. One side engraved with G and 60 on either side of break line.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius
Registered
2022-06-17